A Swiss premiere Proton radiotherapy to treat oesophageal cancer
Villigen, 15.8.2023 - A 67-year old patient presenting with oesophageal cancer was treated today at the Paul Scherrer Institute PSI with a form of radiation provided by protons, i.e. positively charged particles. This is the first time this type of radiotherapy has been used in Switzerland to treat an oesophageal tumour. The five-week course of treatment is part of a European clinical trial involving both PSI and University Hospital Zurich. Medical researchers are investigating whether proton therapy is suitable for treating this type of cancer, as it could potentially reduce lung complications that typically occur with traditional radiotherapy.